# Clinical trials recruiting in Kansas: 929 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 929 trials recruiting or not yet recruiting with a site in Kansas, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Kansas: 929 rows for $46.45, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 17 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/kansas

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 929
- Recruiting or not yet: 929
- Read on: November 19, 2026

## Trials

The 25 newest of 929, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07942844 | Lumbar WBCT vs MRI | University of Kansas Medical Center | Observational | Not yet recruiting | Lumbar Radicular Pain, Lumbar Radiculopathy | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942844) |
| November 16, 2026 | NCT07937696 | A Vaccine (Nous-209) for the Reduction of Colorectal Lesion Size in Patients With Lynch Syndrome | National Cancer Institute (NCI) | Phase 2 | Not yet recruiting | Colorectal Carcinoma, EPCAM Lynch Syndrome, Lynch Syndrome, MLH1 Lynch Syndrome, MSH2 Lynch Syndrome, MSH6 Lynch... | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937696) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| November 5, 2026 | NCT07919483 | Daily Stretching to Improve Walking in Older Patients With Peripheral Artery Disease: The STRETCH PAD Study | Penn State University | Not applicable | Not yet recruiting | Peripheral Artery Disease (PAD), Intermittent Claudication | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919483) |
| November 5, 2026 | NCT07918859 | A Study of Imlunestrant (LY3484356) in Healthy Female Participants | Eli Lilly and Company | Phase 1 | Not yet recruiting | Healthy | 343 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918859) |
| November 4, 2026 | NCT07915791 | A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe... | GlaxoSmithKline | Phase 2 | Recruiting | Pulmonary Disease, Chronic Obstructive | 279 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915791) |
| November 4, 2026 | NCT07915245 | A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise Healthy | Eli Lilly and Company | Phase 1 | Recruiting | Obesity, Overweight | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915245) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| October 29, 2026 | NCT07903311 | Iron Repletion in Cystic Fibrosis | University of Michigan | Phase 4 | Not yet recruiting | Cystic Fibrosis, Iron Deficiencies, Iron Deficiency Diseases | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903311) |
| October 27, 2026 | NCT07896902 | Xenon MRI to Evaluate Changes to Lung Function Following Bronchoscopic Treatment of Air Trapping in Emphysema | Apreo Health, Inc. | Early phase 1 | Recruiting | Air Trapping, Emphysema, Hyperinflation | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896902) |
| October 22, 2026 | NCT07890376 | A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes | Eli Lilly and Company | Phase 2 | Not yet recruiting | Obesity, Overweight | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890376) |
| October 22, 2026 | NCT07888088 | Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults | Bavarian Nordic | Phase 1 | Not yet recruiting | Epstein Barr Virus (EBV) Infection | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888088) |
| October 20, 2026 | NCT07884175 | A Study of Updated mRNA Seasonal Influenza Vaccines | ModernaTX, Inc. | Phase 4 | Recruiting | Seasonal Influenza | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884175) |
| October 9, 2026 | NCT07869498 | Ocular Dysbiosis in Eyelid Disease | Sponsor not shown (see the record) | Observational | Recruiting | Anterior Blepharitis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869498) |
| October 8, 2026 | NCT07866131 | Observational Assessment of Skin Appearance Changes During PRX S Cosmetic Treatment in Participants With Acne-Prone Skin | WiQo S.p.A. | Not applicable | Recruiting | Acne-prone Skin, Skin Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07866131) |
| October 7, 2026 | NCT07863635 | A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations | ModernaTX, Inc. | Phase 4 | Recruiting | SARS-CoV-2 | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863635) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| October 2, 2026 | NCT07856680 | Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Anterior Blepharitis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856680) |
| October 1, 2026 | NCT07851246 | A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age | GlaxoSmithKline | Phase 3 | Recruiting | Influenza, Human | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851246) |
| September 30, 2026 | NCT07850063 | ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and... | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Obesity, Metabolic Dysfunction-associated Steatotic Liver Disease | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850063) |
| September 30, 2026 | NCT07849231 | A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms | Damora Therapeutics | Phase 1 | Recruiting | Myeloproliferative Neoplasms (MPNs) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849231) |
| September 25, 2026 | NCT07842393 | A Study of IBI3042 in Healthy Adult Participants | Fortvita Biologics (USA)Inc. | Phase 1 | Not yet recruiting | Healthy Volunteers (HV) | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842393) |
| September 24, 2026 | NCT07838077 | Modified SOLTIVE Study | Olympus Corporation of the Americas | Observational | Not yet recruiting | Calculi, Renal, Calculi, Urinary, Benign Prostatic Hyperplasia | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838077) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University of Kansas Medical Center | Kansas City | 199 |
| University of Kansas Cancer Center | Kansas City | 118 |
| University of Kansas Hospital-Westwood Cancer Center | Westwood | 79 |
| University of Kansas Cancer Center-Overland Park | Overland Park | 56 |
| University of Kansas Hospital-Indian Creek Campus | Overland Park | 45 |
| University of Kansas Health System Saint Francis Campus | Topeka | 44 |
| Lawrence Memorial Hospital | Lawrence | 43 |
| Salina Regional Health Center | Salina | 41 |
| The University of Kansas Cancer Center - Olathe | Olathe | 41 |
| Central Care Cancer Center - Great Bend | Great Bend | 40 |
| Central Care Cancer Center - Garden City | Garden City | 39 |
| University of Kansas Clinical Research Center | Fairway | 37 |
| Mercy Hospital Pittsburg | Pittsburg | 29 |
| University of Kansas | Kansas City | 29 |
| The University of Kansas Cancer Center | Fairway | 27 |
| Ascension Via Christi Hospitals Wichita | Wichita | 23 |
| The University of Kansas Medical Center | Kansas City | 18 |
| Kansas University Medical Center | Kansas City | 18 |
| Cancer Center of Kansas-Wichita Medical Arts Tower | Wichita | 15 |
| Cancer Center of Kansas - Wichita | Wichita | 14 |
| Cotton O'Neil Cancer Center / Stormont Vail Health | Topeka | 12 |
| University of Kansas Hospital | Kansas City | 11 |
| Cancer Center of Kansas - Salina | Salina | 11 |
| Cancer Center of Kansas | Wichita | 10 |
| Freeman Physician Group of Pittsburg | Pittsburg | 10 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 4 |
| Phase 1 | 82 |
| Phase 1/2 | 49 |
| Phase 2 | 172 |
| Phase 2/3 | 32 |
| Phase 3 | 291 |
| Phase 4 | 23 |
| Not applicable | 140 |
| Observational | 136 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 38 |
| Obesity | 37 |
| Overweight | 29 |
| Breast Neoplasms | 27 |
| Lung Neoplasms | 23 |
| Leukemia, Myeloid, Acute | 23 |
| Prostatic Neoplasms | 22 |
| Colorectal Neoplasms | 22 |
| Heart Failure | 21 |
| Neoplasms | 20 |
| Diabetes Mellitus, Type 2 | 19 |
| Cardiovascular Diseases | 18 |
| Neoplasm Metastasis | 17 |
| Cystic Fibrosis | 16 |
| Melanoma | 16 |
| Urinary Bladder Neoplasms | 16 |
| Ovarian Neoplasms | 15 |
| Lung Diseases, Interstitial | 14 |
| Pulmonary Disease, Chronic Obstructive | 14 |
| Multiple Myeloma | 13 |
| Stroke | 13 |
| Hypertension | 12 |
| Pancreatic Neoplasms | 12 |
| Parkinson Disease | 12 |
| Stomach Neoplasms | 12 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Kansas Medical Center | 81 |
| National Cancer Institute (NCI) | 52 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 35 |
| SWOG Cancer Research Network | 21 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 20 |
| NRG Oncology | 18 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 18 |
| Alliance for Clinical Trials in Oncology | 18 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 16 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 16 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 14 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 13 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 12 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 10 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 10 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 8 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 7 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 7 |
| Kansas City Heart Rhythm Research Foundation | 7 |
| ECOG-ACRIN Cancer Research Group | 7 |
| Duke University | 6 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 6 |
| Children's Oncology Group | 6 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 6 |
| [Alnylam Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/alnylam-pharmaceuticals) | 5 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Kansas

- [Lodges in Kansas, United States](https://specstream.ai/data/businesses/lodges/kansas-united-states)
- [Cardiology practices in Kansas, United States](https://specstream.ai/data/businesses/cardiology-practices/kansas-united-states)
- [Promotional products companies in Kansas, United States](https://specstream.ai/data/businesses/promotional-products-companies/kansas-united-states)
- [Fast food restaurants in Kansas, United States](https://specstream.ai/data/businesses/fast-food-restaurants/kansas-united-states)
- [Wholesalers in Kansas, United States](https://specstream.ai/data/businesses/wholesalers/kansas-united-states)
- [Meat wholesalers in Kansas, United States](https://specstream.ai/data/businesses/meat-wholesalers/kansas-united-states)
